(11-404) Safety and Efficacy of Adding Olanzapine to Standard Antiemetic Therapy for Prevention of Chemo-induced Nausea and Vomiting in Patients Receiving Hematopoietic Stem Cell Transplantation

Wednesday, December 7, 2022

12:30 PM – 1:30 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Oncology/Hematology

Co-Author(s): Kendra Yum, Daniel Park, Jacques Azzi, Alla Keyzner

Primary Author(s)